Target intelligence / Profile preview

ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 (ASAP2)

Target
ASAP2
Molecular classification
Enzyme (GTPase-activating protein, ArfGAP family), Signal transduction regulator
01

Overview

ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 (ASAP2) is a multidomain enzyme that contains an N-terminal coiled-coil region, a pleckstrin homology (PH) domain, an Arf-GAP domain, ankyrin repeats, a proline-rich region, and a C-terminal Src homology 3 (SH3) domain[1][3][8]. It is primarily localized in the Golgi apparatus and plasma membrane, where it plays a key role in activating small GTPases (ARF1, ARF5, ARF6), thereby regulating membrane trafficking, vesicle budding, and constitutive cellular secretion[1][2][6][9]. ASAP2 also modulates phagocytosis and cell migration by interacting with cytoskeletal proteins like paxillin and tyrosine kinases such as PYK2 and SRC[1][3]. Its enzyme activity and protein-protein interactions position it as a potential signaling regulator with relevance to cancer cell biology and possibly other pathological processes[1][2][5][6].

Other names
DDEF2KIAA0400PAG3PAPSHAG1CENTB3AMAP2Pap-alphaPaxillin-associated protein with ARF GAP activity 3Pyk2 C-terminus-associated proteinCentaurin beta 3
02

Biological functions

Regulation of vesicle budding (ARF-mediated)Modulation of constitutive secretionModulation of phagocytosis (via Fc gamma receptor and ARF6)Regulation of cell migration (PXN recruitment to focal contacts)Signal transduction (interaction with PYK2 and SRC)
03

Disease associations

Cancer (implicated in cell migration regulation)Other (potential involvement in Bulbar Polio; limited direct disease linkage)

Beyond the preview

Go deeper on ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 (ASAP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 (ASAP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call